CollabRx Appoints George Lundberg, M.D. as Chief Medical

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
CollabRx Appoints George Lundberg, M.D. as Chief Medical Officer

SAN FRANCISCO, Sept. 4, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq: CLRX ) today announced the appointment of George Lundberg, M.D. as its Chief Medical Officer. Dr. Lundberg will continue in his position as Editor-in-Chief and Chair of the Editorial Advisory Board of CollabRx.

Dr. Lundberg has more than 30 years combined experience as Editor-in-Chief of JAMA (The Journal of the American Medical Association), the 10 American Medical Association specialty journals, American Medical News, Medscape, The Medscape Journal, e-Medicine from Web MD, and MedPage Today from Everyday Health. A frequent lecturer, radio and television guest, and a member of the Institute of Medicine of the National Academy of Sciences, the Industry Standard dubbed Dr. Lundberg "Online Healthcare's Medicine Man" in 2000. Prior to joining CollabRx in 2010, Dr. Lundberg served as the President of the American Society for Clinical Pathology, Professor of Pathology and Associate Director of Laboratories at the Los Angeles County/USC Medical Center for 10 years, and for 5 years was the Professor and Chair of Pathology at the University of California, Davis. He served in the US Army during the Vietnam War, leaving as a lieutenant colonel after 11 years. Prior to his military service , Dr. Lundberg completed a clinical internship in Hawaii and a pathology residency in San Antonio. Called the medical Internet "pioneer" in 1995, Dr. Lundberg holds earned and honorary degrees from North Park College, Baylor University, the University of Alabama (Birmingham and Tuscaloosa), the State University of New York, Syracuse, Thomas Jefferson University and the Medical College of Ohio. Dr. Lundberg has worked in tropical medicine in Central America and Forensic Medicine in New York, Sweden, and England. His major professional interests are toxicology, violence, communication, physician behavior, patient safety, and health system reform.

In addition to serving as Chief Medical Officer and Editor-In-Chief for CollabRx, Dr. Lundberg is presently President and Chair of the Board of Directors of The Lundberg Institute, a Consulting Professor at Stanford University, and Editor at Large for Medscape from WebMD.

"To have as prominent a physician and thought leader in medicine as Dr. Lundberg overseeing our internal processes and the content we provide to users and customers is truly an honor," said Thomas Mika, President & CEO of CollabRx. "George is widely known as a physician and editor of the highest integrity. We are grateful to have had him on our team and we are pleased that he has accepted these additional responsibilities."

About CollabRx

CollabRx, Inc. (Nasdaq: CLRX ) is a recognized leader in cloud-based expert systems to inform health care decision-making. CollabRx uses information technology to aggregate and contextualize the world's knowledge on genomics-based medicine with specific insights from the nation's top cancer experts starting with the area of greatest need: advanced cancers in patients who have effectively exhausted the standard of care. More information may be obtained at http://www.collabrx.com and http://www.cancer.org .

Thomas R. Mika, CEO CollabRx, Inc. 415-248-5350 or James Carbonara, Regional Vice President Hayden IR 646-755-7412

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Webull Faces Legal Scrutiny Over Chinese Ties

Updated Category News Views 5

The Unfolding Drama for Webull Shareholders When you see a ticker like NASDAQ:BULL rolling off your tongue these days, it’s not just about stock prices anymore—it's a whole saga wrapped in legal and geopolitical spice. Following the recent uproar from a House China committee report, Webull found itself thrust into the spotlight for all the wrong reasons. That report...

Continue Reading
Lupin Secures FDA Nod for Key Injectable Drug

Updated Category News Views 4

Lupin's FDA Approval: A Strategic Play in Pharmaceuticals Ah, the thrill of a new approval! Lupin Limited has landed U.S. FDA approval for their Phytonadione Injectable Emulsion, marking a significant stride into the lucrative realm of vitamin K treatments. This approval isn't just a feather in Lupin's cap—it's a calculated move to corner a piece of the estimated $52.3...

Continue Reading
Steel Dynamics Gears Up for Q3 2026 Earnings Update

Updated Category News Views 7

Steel Dynamics Preps for Key Earnings Report Folks, we're staring down the barrel of another quarterly earnings report from Steel Dynamics, Inc., and you can bet this one is gonna have plenty of eyes glued. October 19th, 2026, that's when they'll peel back the curtain on how they fared in Q3. Now, buckle up, because this isn't just a numbers game—it’s a snapshot of...

Continue Reading
Striveworks: Boosting Army's AI Edge in Indo-Pacific

Updated Category News Views 6

The world keeps marching forward, and here’s Striveworks stepping up to the plate with another big move in the military tech space. This isn't your average partnership renewal; this involves a five-year, $200 million deal to enhance battlefield AI as the U.S. Army hones its modern warfare edge in the Indo-Pacific. Now, this isn't just a battle of strategies but a battle...

Continue Reading
Rutter Mills Secures $13M in Virginia Injury Cases

Updated Category News Views 5

The Stakes in Virginia When you drop nine successful injury cases on the scales and they tip over $13 million, that's a story worth dissecting. The two top dogs at Rutter Mills certainly know how to make a splash in the legal puddle, don't they? We're talking about attorneys Adam H. Lotkin and Georgina D. Montgomery here, the legal eagles behind these jaw-dropping...

Continue Reading
PrideStaff: 8 Years Strong on Franchise Times Top 400

Updated Category News Views 4

Where PrideStaff Stands in the Franchise Landscape Here's something the staffing world can't ignore: PrideStaff nailed it again, landing among the giants on the Franchise Times Top 400 for the eighth straight year. Sitting at number 217, this ain't just a lucky streak—this is a sustained homerun, my friends. Consistency Is Key, And They're Holding It Consider this...

Continue Reading
Ajman Tourism Department Hits Internal Audit Milestone

Updated Category News Views 4

A Nod to Standards in Ajman's Tourism Department Folks, it's not every day you see a government department get this kind of spotlight in the internal audit arena, yet here we are. The Ajman Department of Tourism, Culture and Media has snagged Full Conformance with Internal Audit Quality Standards. That’s not just some random feather in their cap but a signal flare in...

Continue Reading
Mexico's Beaches Shine in 2026 Best America Rankings

Updated Category News Views 5

Mexican Shores Turning Heads in 2026 This isn’t just another wave in tourism news; it’s a tidal shift towards Mexico’s sizzling beaches claiming some prime spots on the global travel stage. If you’ve got an eye for tourism dynamics, listen up because Mexico’s sun-soaked shores just snagged six spots among the top 20 beaches in the Americas, according to the...

Continue Reading
CME Group Unveils First Baseball Futures Market

Updated Category News Views 6

A New Pitch in the Financial Ballpark Alright, listen up: CME Group is stepping up to the plate with a game-changer. They’re rolling out the world’s first baseball futures, launching October 12, assuming regulators give the green light. Now, this isn’t just some novelty act; it’s based on the solid groundwork of their FutureSports Performance Indexes (CME FSPI),...

Continue Reading
Aspen Dental Brings Comprehensive Care to Whiteville

Updated Category News Views 6

Bringing Dentistry Closer to Home Now, Whiteville's dental game just got a power-up, with Aspen Dental setting up shop in town. This isn't just another practice popping up—it's a full-on dental hub offering everything from regular cleanings to emergency tooth fixes. And let’s face it, this area's diverse population needs it. The Man Behind the Chair Guess who’s at...

Continue Reading

Top 5 Most Recently Viewed Articles

Zoomcar's Q1 FY 2025-26 Earnings Call: Insights and Future Plans

Updated Category News Views 122

Zoomcar Set to Present Q1 FY 2025-26 Earnings Call Zoomcar Holdings, Inc. (OTCQX: ZCAR) is poised to announce its financial and operational outcomes for the first quarter of the fiscal year 2025-26. This eagerly anticipated report will cover the period ending June 30, 2025, with a release scheduled to occur prior to the market opening on August 14, 2025. Ahead of this...

Continue Reading
Fluence Energy Investors Can Guide Securities Fraud Action

Updated Category News Views 225

Fluence Energy Faces Class Action Lawsuit The Schall Law Firm, a well-known advocate for shareholder rights, has alerted investors about a significant class action lawsuit against Fluence Energy, Inc. (NASDAQ: FLNC). This lawsuit centers on allegations of violations under the Securities Exchange Act of 1934, claiming that Fluence made misleading statements that impacted...

Continue Reading
VTEC's Strategy to Cultivate Skilled Military Professionals

Updated Category News Views 102

VTEC's Initiative at Fort Gillem Campus VTEC has recently announced an ambitious plan to leverage the Fort Gillem Campus, focusing on equipping military personnel with skills that are in high demand across various industries. This initiative is designed to not just meet the needs of the employers but also to help veterans transition seamlessly into civilian jobs....

Continue Reading
Burford Capital's Recent Accomplishments in Legal Finance

Updated Category News Views 507

Burford Capital's Recent Developments and Their Impact Burford Capital Limited, recognized as a leading global finance and asset management firm specialized in law, has recently made significant strides in two crucial areas of litigation finance. These updates are pivotal in demonstrating Burford's ongoing commitment to enhancing its capabilities and operational efficacy...

Continue Reading
Projected Growth in Cardiovascular Health Supplements Market

Updated Category News Views 146

Understanding the Cardiovascular Health Supplements Market The cardiovascular health supplements market has been experiencing significant changes recently, as enthusiasts and health-conscious individuals turn to these products amidst rising cardiovascular disease (CVD) cases. According to various analyses, the market size was valued at approximately USD 11.32 billion...

Continue Reading